Skip to content

    News

      Filter by Topic

      News

      Synthace appoints Dr. Donald Deieso as new board chair

      Dr. Deieso joins at a time of strong momentum: Series C raised in the last year, a doubling of ARR, and expansion to 8 of the world’s top pharma companies.
      Will Patrick
      Will Patrick
       4 min
      News

      UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality

      Building a lab of the future? You're not alone. UCL selects Synthace to help them bridge the gap between digital and physical spaces.
      Will Patrick
      Will Patrick
       4 min
      News

      IDBS Partnership to Streamline Bioprocess Data Management

      Synthace is proud to announce our strategic partnership with IDBS to provide users with state-of-the-art data foundations for experimentation.
      Synthace Team
      Synthace Team
       4 min
      News

      Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

      Synthace is proud to announce that we have raised $35M to expand Access to our revolutionary R&D Technology. Learn more on our website today.
      Synthace Team
      Synthace Team
       9 min
      News

      Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists

      First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
      Synthace Team
      Synthace Team
       8 min
      News

      Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market

      Synthace hires Guy Levy-Yurista as Chief Executive Officer.
      Synthace Team
      Synthace Team
       4 min
      News

      Synthace More than Doubles Its Annual Recurring Revenue; Expands Customer Footprint with the Top Pharma Companies in 2020

      Strong financial performance and achievement of other key milestones demonstrate the growing strength of Synthace’s offering within biopharma and biotech.
      Synthace Team
      Synthace Team
       5 min
      News

      Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development through Automation

      Two European leaders in biopharma and integrative software are working together to advance drug discovery.
      Synthace Team
      Synthace Team
       6 min
      News

      Synthace Rejoins the Pistoia Alliance

      Synthace seeks to support the development and adoption of standards and FAIR (findable, accessible, reusable and interoperable) working practices.
      Synthace Team
      Synthace Team
       4 min